Long non-coding RNA CASC2 suppresses malignancy in human gliomas by miR-21

Cellular Signalling

Volumn 27, Issue 2, 2015, Pages 275-282

  Wang, Ping ^a   Liu, Yun hui ^a   Yao, Yi long ^a   Li, Zhen ^a   Li, Zhi qing ^a   Ma, Jun ^a   Xue, Yi xue ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

CASC2; Glioma; Invasion; Migration; MiR 21; Proliferation

Indexed keywords

CANCER SUSCEPTIBILITY CANDIDATE 2 PROTEIN; LONG UNTRANSLATED RNA; MICRORNA 21; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; ARGONAUTE PROTEIN; CASC2 PROTEIN, HUMAN; EIF2C2 PROTEIN, HUMAN; MICRORNA; MIRN21 MICRORNA, HUMAN;

APOPTOSIS; ARTICLE; BIOINFORMATICS; BIOTINYLATION; CANCER GROWTH; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; EMBRYO; GLIOBLASTOMA; GLIOMA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; LUCIFERASE ASSAY; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; UPREGULATION; 3' UNTRANSLATED REGION; CELL MOTION; GENETIC TRANSFECTION; GENETICS; GLIOMA; METABOLISM; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; SEQUENCE ALIGNMENT; TUMOR CELL LINE;

3' UNTRANSLATED REGIONS; APOPTOSIS; ARGONAUTE PROTEINS; BASE SEQUENCE; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DOWN-REGULATION; GLIOMA; HUMANS; MICRORNAS; RNA, LONG NONCODING; SEQUENCE ALIGNMENT; TRANSFECTION; TUMOR SUPPRESSOR PROTEINS;

EID: 84918809202     PISSN: 08986568     EISSN: 18733913     Source Type: Journal    
DOI: 10.1016/j.cellsig.2014.11.011     Document Type: Article

References (25)

1. Cuddapah V.A., Robel S., Watkins S., Sontheimer H. Nat. Rev. Neurosci. 2014, 15:455-465.
2. Ellis B.C., Molloy P.L., Graham L.D. Front. Genet. 2012, 3:270.
3. Wang P., Ren Z., Sun P. J. Cell. Biochem. 2012, 113:1868-1874.
4. Zhang J.X., Han L., Bao Z.S., Wang Y.Y., Chen L.Y., et al. Neuro Oncol. 2013, 15:1595-1603.
5. Baldinu P., Cossu A., Manca A., Satta M.P., Sini M.C., et al. Hum. Mutat. 2004, 23:318-326.
6. Baldinu P., Cossu A., Manca A., Satta M.P., Sini M.C., et al. Anticancer Res. 2007, 27:235-243.
7. Hayes J., Peruzzi P.P., Lawler S. Trends Mol. Med. 2014, 20:460-469.
8. Si M.L., Zhu S., Wu H., Lu Z., Wu F., et al. Oncogene 2007, 26:2799-2803.
9. Asangani I.A., Rasheed S.A., Nikolova D.A., Leupold J.H., Colburn N.H., et al. Oncogene 2008, 27:2128-2136.
10. Wu L., Li G., Feng D., Qin H., Gong L., et al. Diagn. Pathol. 2013, 8:200.
11. Zhou X., Zhang J., Jia Q., Ren Y., Wang Y., et al. Oncol. Rep. 2010, 24:195-201.
12. Gabriely G., Wurdinger T., Kesari S., Esau C.C., Burchard J., et al. Mol. Cell. Biol. 2008, 28:5369-5538.
13. Yang C.H., Yue J., Pfeffer S.R., Fan M., Paulus E., et al. J. Biol. Chem. 2014, 289:25079-25087.
14. Cesana M., Cacchiarelli D., Legnini I., Santini T., Sthandier O., et al. Cell 2011, 147:358-369.
15. Liu X.H., Sun M., Nie F.Q., Ge Y.B., Zhang E.B., et al. Mol. Cancer 2014, 13:92.
16. Serviss J.T., Johnsson P., Grandér D. Front. Genet. 2014, 5:234.
17. Moran V.A., Perera R.J., Khalil A.M. Nucleic Acids Res. 2012, 40:6391-6400.
18. Steck P.A., Ligon A.H., Cheong P., Yung W.K., Pershouse M.A. Gene Chromosome Cancer 1995, 12:255-261.
19. Tay Y., Rinn J., Pandolfi P.P. Nature 2014, 505:344-352.
20. Liu Q., Huang J., Zhou N., Zhang Z., Zhang A., et al. Nucleic Acids Res. 2013, 41:4976-4987.
21. Yang C.H., Yue J., Pfeffer S.R., Handorf C.R., Pfeffer L.M. J. Biol. Chem. 2011, 286:39172-39178.
22. Xu L.F., Wu Z.P., Chen Y., Zhu Q.S., Hamidi S., et al. PLoS One 2014, 9:e103698.
23. Gabriely G., Wurdinger T., Kesari S., Esau C.C., Burchard J., et al. Mol. Cell. Biol. 2008, 28:5369-5380.
24. Kwak H.J., Kim Y.J., Chun K.R., Woo Y.M., Park S.J., et al. Oncogene 2011, 30:2433-2442.
25. Papagiannakopoulos T., Shapiro A., Kosik K.S. Cancer Res. 2008, 68:8164-8172.